Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Research Brief: Auguste D. Did Not Have Volga German Mutation
16 September 2011. Based on molecular genetic data, researchers in Seattle proposed last year that Alois Alzheimer’s first patient likely carried the same familial AD mutation common to Volga Germans (ARF related news story on Yu et al., 2010). The evidence was circumstantial, and a study in this month’s Archives of Neurology definitively disproves the hypothesis. Sequencing DNA from century-old brain tissue of Alzheimer’s quintessential case, researchers led by Ulrich Mueller of the Institute for Human Genetics in Giessen, Germany, report that Auguste Deter did not, in fact, carry the presenilin-2 N141I mutation.

Senior author Manuel Graeber rediscovered Auguste D.’s original slides in the basement of the Institute of Neuropathology at the University of Munich while finishing his clinical training and habilitation thesis there in the 1990s (Graeber, 1999). Graeber, now at the University of Sydney in Australia, did not contribute to the Seattle study, and told ARF he has “always argued against carrying out single-gene tests on this precious material.” However, Mueller “convinced me on this one occasion.” Mueller and Graeber worked together on the original analysis (Graeber et al., 1997), Graeber wrote.

Thomas Bird and Chang-En Yu of the University of Washington, who led the Seattle analysis, wrote in response to Mueller’s findings: “We thank Dr. Mueller and colleagues for their careful molecular analysis of this valuable tissue. The etiology and biological pathogenesis initiating the early onset of neuritic plaques and neurofibrillary tangles in Auguste D. remains a mystery today, just as it was for Alzheimer more than 100 years ago.”

Having ruled out the PS2 N141I mutation, Graeber’s team plans to eventually sequence other portions of Auguste D.’s DNA to find which mutations or known AD risk variants she might have had. “But I think one should wait until technology is so mature that a complete genome scan can be done on a minute portion of this archival material,” Graeber noted. “The slides are valuable not only from a historical point of view, but their quality is such that they can serve as an inspiration for anyone with an interest in brain research (see examples here, see photos in Alois Alzheimer biographical story).”—Esther Landhuis.

References:
Mueller U, Winter P, Graeber MB. Alois Alzheimer's Case, Auguste D., Did Not Carry the N141I Mutation in PSEN2 Characteristic of Alzheimer Disease in Volga Germans. Arch Neurol. 2011;68(9):1210-1211. Abstract

Bird TD, Yu CE. Alois Alzheimer's Case, Auguste D., Did Not Carry the N141I Mutation in PSEN2 Characteristic of Alzheimer Disease in Volga Germans—Reply. Arch Neurol. 2011;68(9):1211.

 
Comments on News and Primary Papers
  Primary Papers: Alois Alzheimer's case, Auguste D., did not carry the N141I mutation in PSEN2 characteristic of Alzheimer disease in Volga Germans.

Comment by:  Roberta Diaz Brinton, ARF Advisor
Submitted 17 September 2011  |  Permalink Posted 19 September 2011
  I recommend this paper

  Comment by:  Jean-François Foncin
Submitted 24 September 2011  |  Permalink Posted 24 September 2011

Was the first step of any genetic investigation, namely the study of the family history of the proband, undertaken in the case of Auguste D. beyond the succinct notes in her clinical record? Her father died aged 45 (no diagnosis given), her mother aged 64 of pneumonia, her three brothers are "healthy" (their ages not given) and "there is no mental illness in the family." Given the high "a priori" probability of dominant inheritance in instances of what is now called early-onset Alzheimer's disease (EOAD), the age at death of both her parents is within two standard deviations for affected EOAD family members (1). Incidentally, we found "pneumonia" as the registered cause of death for a number of EOAD patients in our Calabrian study. There is a 0.8 probability for at least one of her brothers and 0.5 for her daughter to have been a carrier, and a non-negligible one for contemporary descendants to be affected.

A family reconstruction along the lines of what we did for family N (FAD1), which later came to be the index for the PS1 M146L mutation, would certainly be feasible, and...  Read more

  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad